A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Abbott’s FreeStyle Libre 3 continuous glucose monitor for diabetes management in patients four years of age and older; device is smallest, thinnest CGM monitor in the world, will be available at pharmacies later in 2022
Published: June 02, 2022 by Fitch Solutions Sector Intelligence
Long COVID may be associated with patients with high viral loads, autoantibodies, reactivation of Epstein-Barr virus, type 2 diabetes; data suggests administering antivirals after diagnosis may rapidly eliminate virus, prevent long-term symptoms: study
Published: May 31, 2022 by CE Noticias Financieras
2022 Pharmapack Award winners include reusable Aria Smart Autoinjector, Aidaptus disposable auto-injector, SKYTROFA Auto-Injector, Autotest COVID-VIRO ALL IN, TouStar reusable insulin pens, and YpsoMate On, the world’s first pre-filled auto-injector
Published: May 25, 2022 by PharmaBiz
Global negative pressure wound therapy market projected to grow to US$3.1B by 2026, with CAGR growth of 6.1% from 2022 to 2026; growth driven by rise in chronic diseases and diabetes, growing aging population, with US market reaching US$1.2B in 2022
Published: May 23, 2022 by PR Newswire
LabCorp launches at-home diabetes screening kit in US with 97% accuracy co-developed with device owner Weavr Health; LabCorp only commercial lab offering the test, which measures hemoglobin A1c from a small blood sample
Published: May 19, 2022 by Zack's Commentary

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count